<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/045C02DA-35C7-4898-928B-EBF4821E5C04"><gtr:id>045C02DA-35C7-4898-928B-EBF4821E5C04</gtr:id><gtr:name>Specialty Magnetics Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Radiotherapy and Imaging</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/045C02DA-35C7-4898-928B-EBF4821E5C04"><gtr:id>045C02DA-35C7-4898-928B-EBF4821E5C04</gtr:id><gtr:name>Specialty Magnetics Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/43B575F0-8764-4AAF-B842-B09F0D8ED177"><gtr:id>43B575F0-8764-4AAF-B842-B09F0D8ED177</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Osmund</gtr:otherNames><gtr:surname>Leach</gtr:surname><gtr:orcidId>0000-0002-0756-5368</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701533"><gtr:id>631B665D-2B0F-4ACF-8E79-104972E583CA</gtr:id><gtr:title>Advancing the Application of Magnetic Resonance in Cancer: Structural, Functional and Molecular Studies of Tumours and</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701533</gtr:grantReference><gtr:abstractText>This proposal aims to establish a leading edge 3T magnetic resonance facility to support major
programmes of research in cancer imaging that focus on tumour detection, assessment of
disease extent and aggressiveness, and evaluation of new cancer therapies. The proposal will
build on 20 years of experience in applying magnetic resonance to cancer at The Institute of
Cancer Research and the Royal Marsden Hospital enhancing major research programmes
funded through Cancer Research UK and through NHS research and development activities.
The increased signal available at 3T allows high-resolution images for improved tumour
detection, but also enables functional information to be acquired, which may not be possible at
conventional field strengths. Much of the planned research uses functional images, where the
behaviour and characteristics of tumour are measured, in addition to their extent. The higher
field strength provides increased sensitivity to signals from MR contrast agents, allowing more
accurate assessment of tumour blood supply. The water composition and viability of cells within
a tumour will also be assessed more easily and the detailed interrogation of biochemical
pathways will be made possible using multi-nuclear MR spectroscopy. This will enable
assessment of the action of new anti-cancer drugs on specific processes in cells.</gtr:abstractText><gtr:technicalSummary>Support for 3T clinical MRI scanner to add to existing state of art CT, PET-CT and SPECT facilities. System to be integrated within current MR unit within Royal Marsden NHS Foundation Trust at Sutton which is jointly operated with ICR.

Provide a multi-modality molecular imaging resource to probe tumor biology: identify metabolic signatures of tumors; develop functional imaging (tumour vascularity, perfusion, oxygenation and cellularity) to monitor treatment response &amp;amp; guide treatment strategies in adult &amp;amp; paediatric patients;characterize tumour heterogeneity and link to prognosis; improve tumour staging; develop biomarkers of drug action.</gtr:technicalSummary><gtr:fund><gtr:end>2012-10-25</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>615228</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>ETH Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Institute for Biomedical Engineering</gtr:department><gtr:description>DNP Imaging</gtr:description><gtr:id>37C930ED-3308-4A3D-B0FC-930EB09B5113</gtr:id><gtr:impact>Abstracts to international meetings
Multidisciplinary: Engineering, Physics, Chemistry, Biochemistry</gtr:impact><gtr:outcomeId>qBhr6UUeHmJ-1</gtr:outcomeId><gtr:partnerContribution>Novel spectroscopic imaging methods</gtr:partnerContribution><gtr:piContribution>Implementation and evaluation of mew imaging methods using hyperpolarised probes</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>London clinical 7T consortium</gtr:description><gtr:id>11E11BCB-7CF5-42F2-A26A-A66E12954A46</gtr:id><gtr:impact>Wellcome Award &amp;pound;4M. 
Very multidisciplinary, many specialities, clinical, physics, radiology, surgery, neurology, psychiatry, engineering.</gtr:impact><gtr:outcomeId>58bd9ec571b210.01667683-1</gtr:outcomeId><gtr:partnerContribution>Together we have developed scientific programmes in different medical areas where 7T MRI is relevant. WE will seek more specific funding of these aspects. Funding for the 7T has been awarded.</gtr:partnerContribution><gtr:piContribution>This collaboration is establishing, with support for the Wellcome Trust, a clinical 7T MR system to support research in London</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>CRUK Centre for Cancer Therapeutics</gtr:department><gtr:description>MCT1 inhibitor clinical trial</gtr:description><gtr:id>36921AC6-1A4F-433B-826B-75BBD3E1DCA7</gtr:id><gtr:impact>Multidisciplinary: Clinical Oncology, radiology, pharmacology, pathology, chemistry, molecular biology, physics, imaging</gtr:impact><gtr:outcomeId>56d8baf9589172.06567860-1</gtr:outcomeId><gtr:partnerContribution>CRUK CCT is funding an dcoordinating this study. The clinical trial PI is based at Newcastle. Our Drug Development Unit is contributing measurements.</gtr:partnerContribution><gtr:piContribution>This is a phase I clinical trial of a new MCT1 inhibitor as part of a collaboration between CRUK and Astra Zeneca. 
We have developed new measurement methodologies for pH and lactate, and established the former at the two clinical centres, analyzing the results to data. We plan to introduce lactate measurements at both centres in the next stage.
We have also performed cell and in vivo preclinical measurements as a part of this collaboration to guide further studies.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>London clinical 7T consortium</gtr:description><gtr:id>F5F18522-1483-4013-9750-723150CC4CC3</gtr:id><gtr:impact>Wellcome Award &amp;pound;4M. 
Very multidisciplinary, many specialities, clinical, physics, radiology, surgery, neurology, psychiatry, engineering.</gtr:impact><gtr:outcomeId>58bd9ec571b210.01667683-2</gtr:outcomeId><gtr:partnerContribution>Together we have developed scientific programmes in different medical areas where 7T MRI is relevant. WE will seek more specific funding of these aspects. Funding for the 7T has been awarded.</gtr:partnerContribution><gtr:piContribution>This collaboration is establishing, with support for the Wellcome Trust, a clinical 7T MR system to support research in London</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cancer Imaging Centres Collaboration</gtr:description><gtr:id>218393B2-0212-47D4-8ADC-C51616F6A129</gtr:id><gtr:impact>potential collaboration agreement with GE</gtr:impact><gtr:outcomeId>QHdYc6NBJRM-5</gtr:outcomeId><gtr:partnerContribution>training, clinical trials, radiopharmaceutical development</gtr:partnerContribution><gtr:piContribution>Projects in bioinformatics, training, clinical trials, preclinical investigations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>London clinical 7T consortium</gtr:description><gtr:id>F88C13CB-DF51-468F-8864-810213710779</gtr:id><gtr:impact>Wellcome Award &amp;pound;4M. 
Very multidisciplinary, many specialities, clinical, physics, radiology, surgery, neurology, psychiatry, engineering.</gtr:impact><gtr:outcomeId>58bd9ec571b210.01667683-3</gtr:outcomeId><gtr:partnerContribution>Together we have developed scientific programmes in different medical areas where 7T MRI is relevant. WE will seek more specific funding of these aspects. Funding for the 7T has been awarded.</gtr:partnerContribution><gtr:piContribution>This collaboration is establishing, with support for the Wellcome Trust, a clinical 7T MR system to support research in London</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cancer Imaging Centres Collaboration</gtr:description><gtr:id>5A02504C-07CB-44A8-AB26-A451F8584717</gtr:id><gtr:impact>potential collaboration agreement with GE</gtr:impact><gtr:outcomeId>QHdYc6NBJRM-3</gtr:outcomeId><gtr:partnerContribution>training, clinical trials, radiopharmaceutical development</gtr:partnerContribution><gtr:piContribution>Projects in bioinformatics, training, clinical trials, preclinical investigations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Northern Institute for Cancer Research Newcastle</gtr:department><gtr:description>MCT1 inhibitor clinical trial</gtr:description><gtr:id>9596FCFE-EDD4-4B11-9117-7E1FAC4A9DFA</gtr:id><gtr:impact>Multidisciplinary: Clinical Oncology, radiology, pharmacology, pathology, chemistry, molecular biology, physics, imaging</gtr:impact><gtr:outcomeId>56d8baf9589172.06567860-2</gtr:outcomeId><gtr:partnerContribution>CRUK CCT is funding an dcoordinating this study. The clinical trial PI is based at Newcastle. Our Drug Development Unit is contributing measurements.</gtr:partnerContribution><gtr:piContribution>This is a phase I clinical trial of a new MCT1 inhibitor as part of a collaboration between CRUK and Astra Zeneca. 
We have developed new measurement methodologies for pH and lactate, and established the former at the two clinical centres, analyzing the results to data. We plan to introduce lactate measurements at both centres in the next stage.
We have also performed cell and in vivo preclinical measurements as a part of this collaboration to guide further studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cancer Imaging Centres Collaboration</gtr:description><gtr:id>BD21738C-D4D7-4F11-B503-6D07FEBBC8EF</gtr:id><gtr:impact>potential collaboration agreement with GE</gtr:impact><gtr:outcomeId>QHdYc6NBJRM-2</gtr:outcomeId><gtr:partnerContribution>training, clinical trials, radiopharmaceutical development</gtr:partnerContribution><gtr:piContribution>Projects in bioinformatics, training, clinical trials, preclinical investigations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cancer Imaging Centres Collaboration</gtr:description><gtr:id>422FAA90-38B9-403E-AB8A-DB7246C790B2</gtr:id><gtr:impact>potential collaboration agreement with GE</gtr:impact><gtr:outcomeId>QHdYc6NBJRM-4</gtr:outcomeId><gtr:partnerContribution>training, clinical trials, radiopharmaceutical development</gtr:partnerContribution><gtr:piContribution>Projects in bioinformatics, training, clinical trials, preclinical investigations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cancer Imaging Centres Collaboration</gtr:description><gtr:id>F4E2C023-16DF-44DB-8F8B-08D6ED4D7C8F</gtr:id><gtr:impact>potential collaboration agreement with GE</gtr:impact><gtr:outcomeId>QHdYc6NBJRM-1</gtr:outcomeId><gtr:partnerContribution>training, clinical trials, radiopharmaceutical development</gtr:partnerContribution><gtr:piContribution>Projects in bioinformatics, training, clinical trials, preclinical investigations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Specialty Magnetics Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>design and testing of specialised components</gtr:description><gtr:id>283C414B-812A-432A-BB88-9B94871833BF</gtr:id><gtr:impact>Aiding understanding of requirements for breast imaging and biopsy equipment, and the compatibility of display and control equipment.</gtr:impact><gtr:outcomeId>j5PnhUrVJXJ-1</gtr:outcomeId><gtr:partnerContribution>Test devices for improved diagnosis and treatment of cancer</gtr:partnerContribution><gtr:piContribution>Investigating feasibility of prototype devices, checking MR compatibility of such devices.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Radiology</gtr:department><gtr:description>NCI 31P project</gtr:description><gtr:id>446A061B-6D58-4C38-B5E1-39D1575787D4</gtr:id><gtr:impact>See publication list multicentre evaluation of methodology. 
In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. Arias-Mendoza F, Payne GS, Zakian KL, Schwarz AJ, Stubbs M, Stoyanova R, Ballon D, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR.

NMR Biomed. 2006 Jun;19(4):504-12.


Multidisciplinary Physics, Engineering, Medicine, Biochemistry</gtr:impact><gtr:outcomeId>BWX3z6w37wQ-1</gtr:outcomeId><gtr:partnerContribution>Shared expertise, improved methodology</gtr:partnerContribution><gtr:piContribution>Expertise, accruing patients, implementing and testing methods</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Imaging research open evening</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>55ECE6B9-6E0C-4249-9733-06BE02338ADE</gtr:id><gtr:impact>This related to NIHR Clinical Research Facilities coordinated events, designed to encourage participation in clinical trials and inform potential participants of what imaging studies involved</gtr:impact><gtr:outcomeId>56d8bec7a48d94.93932133</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PPI strategy and engagement with patient representatives</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C422666F-4BE0-43FB-89C0-D3957E2ED119</gtr:id><gtr:impact>Several patient representatives have been engaged and attend some meetings of Clinical Research Facility Management Group

PPI strategy developed with their input approved by NIHR.</gtr:impact><gtr:outcomeId>hfWVxWFpf2v</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PPI imaging open evening</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>616723A3-5EDF-40DE-A73B-1603C180FCE3</gtr:id><gtr:impact>Talks, posters and visits resulted in discussion; questionnaires, quiz engaged interest

Engagement with a wide number of individuals,and charities, resulting in better understanding of role of imaging</gtr:impact><gtr:outcomeId>5464d5fc6b66a8.59183781</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discovery Club 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>21953683-C496-4583-B51F-4BBD3B32BD1E</gtr:id><gtr:impact>60 or so leading individuals attended, leading to positive funding support for research

Invitations to propose funding requests to a number of Trusts.</gtr:impact><gtr:outcomeId>TUJJQ1LSEe5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Partnership for fellowship</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8F9F4139-9096-4BC2-9999-AC38FFAFB7F1</gtr:id><gtr:impact>Guidance in the scientific programme, and arrangements for patient liaison.

Successful Fellowship application.</gtr:impact><gtr:outcomeId>meh4nZ7FtPH</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Developing Policy on Incidental Findings</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3D40FE3E-7D47-45CD-80F2-BBC4475A115D</gtr:id><gtr:impact>85 Professionals including ethicists, funders, public attended a workshop in 2010. 
Ethical Management of Research Imaging
1st July 2010; Wellcome Trust, Gibbs Building, 215 Euston Road, London, UK
 Issues were identified, a consensus reached on some topics, minimum standards developed. A report has been made available via web sites. A publication has been submitted.

Discussion identified a range of views and approaches amongst researchers. Consensus was achieved on a minimum standard. A publication has been submitted.</gtr:impact><gtr:outcomeId>YjeaJYcdE9Q</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Inteview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB370233-ECA7-4826-A976-2C14698516A5</gtr:id><gtr:impact>INterview on the Naked Scientist BBC Programme broadcast to local radio, internet and podcast, together with responding to audience questions

Positive response from broadcasters and Institute Press Office.</gtr:impact><gtr:outcomeId>XLp7tzyHSMq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Opening of 3T facility</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4891FCF1-D096-4968-AC9D-46EE40621454</gtr:id><gtr:impact>Press coverage in national and local media

Coverage in national and local press and other media</gtr:impact><gtr:outcomeId>AE5QqDDUxQs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>476925</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GAP2 FDHT</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Movember</gtr:fundingOrg><gtr:id>8FEAC73B-1233-48DD-BFF3-FC5887F5BF4E</gtr:id><gtr:outcomeId>ApFfVwi4bM1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15956</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bursary/Bowel Disease Research Foundation</gtr:description><gtr:fundingOrg>Bowel Disease Research Foundation (BDRF)</gtr:fundingOrg><gtr:id>3BD2BC16-67CC-4476-857E-70EF88B57AD8</gtr:id><gtr:outcomeId>ksb8dQmPDY90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1400150</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EP/H046526/1 EPSRC Platform Grant: Multimodality Techniques for Cancer Diagnosis and Therapy</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H046526/1</gtr:fundingRef><gtr:id>6A8D102A-B539-4533-89E0-94B6DE830CD4</gtr:id><gtr:outcomeId>YHdghUVW94k0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway funding scheme</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>027047B5-0FE1-4FDD-A746-34842CA9996F</gtr:id><gtr:outcomeId>L3Ar861zTx90</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>266210</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Cancer Institute (NCI) R01 grant</gtr:description><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>DE74D00E-24A2-4D3F-9AEA-9B3DB2B7F6E1</gtr:id><gtr:outcomeId>a6tpJg7i3Dj0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CR-UK and EPSRC Cancer Imaging Centre</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C1060/A10334</gtr:fundingRef><gtr:id>6381085C-D628-4B2E-B6FB-039BC1D2F40F</gtr:id><gtr:outcomeId>r-7491377962.27948506899ae0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaborative Award in Science application Multi-User Ultra-High Field Clinical Imaging Research Centre for London</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>201526/Z/16/Z</gtr:fundingRef><gtr:id>CA8FF23C-1CDC-4DC5-8277-D2E105E2764E</gtr:id><gtr:outcomeId>58c020b2475e20.26737786</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator Award</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>DA00616A-43F9-4716-B0A9-00DDBAB23011</gtr:id><gtr:outcomeId>JoceYSPcEmq0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>948461</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EP/H046410/1 EPSRC Intelligent Imaging: Motion, Form and Function Across Scale</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H046410/1</gtr:fundingRef><gtr:id>7D50ECAA-A094-42CC-BD9D-57DC83FD30F4</gtr:id><gtr:outcomeId>rJ3C9dk74wX0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Radiotherapy Research Programme</gtr:description><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>A19727</gtr:fundingRef><gtr:id>4769CA2A-7805-4C4F-BEBE-CA46031FAF29</gtr:id><gtr:outcomeId>545cbff90f0943.79640657</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>198520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR TRF</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>TRF-2013-06-003</gtr:fundingRef><gtr:id>61E3FD40-63AE-4D4E-BCE0-A5858377C520</gtr:id><gtr:outcomeId>CmiiPtfzMHb</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK and EPSRC Paediatric Cancer Imaging Programme</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>88FC3EF8-3A0D-4329-913F-D37ACC6BA1C8</gtr:id><gtr:outcomeId>RD87jduT6pu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203251</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Healthcare Science Fellowship</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>HCS-D13-04-002</gtr:fundingRef><gtr:id>C8EB6679-5A82-43D4-A5EA-2A33DD78DD47</gtr:id><gtr:outcomeId>545cdd1e268f74.07039453</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Focused Ultrasound Foundation Centre of Excellence</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Focused Ultrasound Foundation</gtr:fundingOrg><gtr:fundingRef>none</gtr:fundingRef><gtr:id>1EA21A07-0159-43EA-B954-D97703AF2AF5</gtr:id><gtr:outcomeId>U92FbtXJiET</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2812128</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR CRF</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>79CF3A61-E96A-4B1B-BBC3-92300CBABC80</gtr:id><gtr:outcomeId>Ft3VCDUdXGm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7607000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CR-UK Cancer Imaging Centre</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C1060/A16464</gtr:fundingRef><gtr:id>77B70563-23E6-48E0-8DFF-037D3A3238EB</gtr:id><gtr:outcomeId>r-4546431316.57171206899824</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9619509</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC MR-Linac Clinical Infrastructure award</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M009068/1</gtr:fundingRef><gtr:id>F25C43DF-6FA0-48AA-BBB2-65B63B1799D7</gtr:id><gtr:outcomeId>545cc0b5375833.33920838</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>162000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK BIDD</gtr:description><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C7270/A13149</gtr:fundingRef><gtr:id>2AC0D6CE-D9DA-444F-BF2F-5CDF1BFE19E6</gtr:id><gtr:outcomeId>gJap7HRynU2</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator Award</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>NF-SI-0512-10162</gtr:fundingRef><gtr:id>000A6AED-BC8B-4841-80DD-808F5C2864F9</gtr:id><gtr:outcomeId>eQN4Qg7nXpM</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Experimental Cancer Medicine Centres</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>5688EE2F-D19A-4CCF-8DE1-2B2157FC48C5</gtr:id><gtr:outcomeId>GYNnM5ni2Tv</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66539</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Biological Sciences Committee - Equipment Allocation</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>3CDB6B34-4F42-4C7D-956C-22DCF02C3EEF</gtr:id><gtr:outcomeId>YAJJPoDiUVu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A range of software to analyse MRI breast images, including segmentation and density analysis</gtr:description><gtr:grantRef>G0701533</gtr:grantRef><gtr:id>123B54E3-BC2C-4606-AD4E-8CA36C3B71A6</gtr:id><gtr:impact>Demonstration of association between density and breast cancer risk</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>hkteJtcY74B</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Software for breast cancer analysis</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CIRC management group Singapore</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>B943E04A-128B-40F9-B7E5-0DF32E9AF356</gtr:id><gtr:outcomeId>Rgavhikv9s3</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EPSRC Strategy Review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D8C1D7DB-73D5-4361-8FDC-82A71F7F4CFA</gtr:id><gtr:outcomeId>r6PkgXFerz2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Incidental Findings</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DBC99FAF-F44D-4666-ABBB-019351ED147D</gtr:id><gtr:outcomeId>SZDmqBVcv9e</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.bmj.com/content/351/bmj.h5190.long</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NCRI Imaging Review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>721EC319-BFC1-4E0B-9C61-198617A720E0</gtr:id><gtr:outcomeId>hRvnPfYQxWG</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>This is an early stage clinical trial supported by DR-UK DDO under an agreement with AstraZeneca. Advanced MRI techniques are being used to identify proof of mechanism of action in Phase I/II trial jointly with Univ Newcastle</gtr:description><gtr:id>7F0CFCC8-2B26-447A-BCE6-4EB255E31480</gtr:id><gtr:impact>Measurements of pH standardised and implemented at 2 centres. Publication on methodology now on line.</gtr:impact><gtr:outcomeId>oWKEdz2cPna</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>MCT1 inhibitor AZD3965</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New 1H/31P rf surface coil design is being tested. Also internal cervix Rx coil.</gtr:description><gtr:id>DE808A53-0CF4-4A6B-A6C3-D6C8CD8FEE0F</gtr:id><gtr:impact>A coil for 31P/1H MRS has been built and is being tested.
A coil for cervical imaging and spectroscopy has been built and is being tested. A coil for measuring solution-state 13C DNP compounds has been interfaced and preliminary measurements performed.</gtr:impact><gtr:outcomeId>VW6XBpcWMMx</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RF Coils</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>magneetic resonance technique for measuring lactate in vivo</gtr:description><gtr:id>757357ED-E582-49E7-97D6-3728B43917FA</gtr:id><gtr:impact>still in implementation</gtr:impact><gtr:outcomeId>56d8bc0f6c2fc9.11594084</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>multiple quantum lactate measurements</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>631EF66E-9CFA-4B84-8E3A-C35863EAB8D7</gtr:id><gtr:title>Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>5a8c3fb68c6115.13339907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBA5B26F-3326-4F71-9205-A05D09C62FDD</gtr:id><gtr:title>Imaging hypoxia in tumours with advanced MRI.</gtr:title><gtr:parentPublicationTitle>The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0656e7aa5af75856d707bf21534a555b"><gtr:id>0656e7aa5af75856d707bf21534a555b</gtr:id><gtr:otherNames>Price JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1824-4785</gtr:issn><gtr:outcomeId>545ca8313e1fc4.06430170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>832957FC-EE33-41BC-B598-3E167F80BA98</gtr:id><gtr:title>Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59e33e0b795c8d66c718228a3e4069ba"><gtr:id>59e33e0b795c8d66c718228a3e4069ba</gtr:id><gtr:otherNames>Rata M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>56d8672786d033.67548900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3618BAB0-E9F5-41C8-94D1-9C76FD1B6C0F</gtr:id><gtr:title>Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1028eaed17bea4a521d32b3ed39f897e"><gtr:id>1028eaed17bea4a521d32b3ed39f897e</gtr:id><gtr:otherNames>Riches SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>56d8b33299fe15.16462578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7D08DF4-135D-4A58-B2F7-66BB6569FE1A</gtr:id><gtr:title>Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cb2b530ca6d8d3f3ecd9b026b702cd6"><gtr:id>7cb2b530ca6d8d3f3ecd9b026b702cd6</gtr:id><gtr:otherNames>Koh DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>pm_15918_28_22826385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10273DF0-9BFE-46F3-BB91-A5C4BB32F296</gtr:id><gtr:title>Appearances of colorectal hepatic metastases at diffusion-weighted MRI compared with histopathology: initial observations.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b089014f241367814f40a3585e12e655"><gtr:id>b089014f241367814f40a3585e12e655</gtr:id><gtr:otherNames>Scurr ED</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>pm_15918_28_21224302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25678437-43AF-460B-91E2-42920B605ADD</gtr:id><gtr:title>A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.</gtr:title><gtr:parentPublicationTitle>Cancer treatment reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf64a57f6083e244c3656d97a6680fd8"><gtr:id>bf64a57f6083e244c3656d97a6680fd8</gtr:id><gtr:otherNames>Bollineni VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7372</gtr:issn><gtr:outcomeId>58c68af9113761.15617768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C68E31D8-20BA-415E-887A-8100C3C8E2EB</gtr:id><gtr:title>TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c888bf5ce01437df710f750fd71145d0"><gtr:id>c888bf5ce01437df710f750fd71145d0</gtr:id><gtr:otherNames>Basharat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d6d01bce1109.89134613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44CBE279-3423-4407-8701-6C36629C5572</gtr:id><gtr:title>Quantitative evaluation of contrast agent uptake in standard fat-suppressed dynamic contrast-enhanced MRI examinations of the breast.</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131c41688be7a01aca68ec749ba99a5f"><gtr:id>131c41688be7a01aca68ec749ba99a5f</gtr:id><gtr:otherNames>Kousi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn><gtr:outcomeId>5a9d29ec08be77.73384746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB6AC98B-AA51-4B74-8EE6-AB1E9629365D</gtr:id><gtr:title>Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53843164bc282e8ccf3eeb83033b681"><gtr:id>a53843164bc282e8ccf3eeb83033b681</gtr:id><gtr:otherNames>Fryer RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545267e9e4d672.95448271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DED85DC-9204-46C5-914B-E70D5D50EF9B</gtr:id><gtr:title>Magnetic resonance-guided high-intensity-focused ultrasound for the treatment of cancer-related pain.</gtr:title><gtr:parentPublicationTitle>Pain management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83a3b91fbe7de195447d6328352ad089"><gtr:id>83a3b91fbe7de195447d6328352ad089</gtr:id><gtr:otherNames>deSouza N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1758-1869</gtr:issn><gtr:outcomeId>58c68af9bd4923.71549006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAA3B86A-BB6B-4E8C-A3F2-8DD85757CB2D</gtr:id><gtr:title>Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1c236b825349267d6c91adda200d60"><gtr:id>0b1c236b825349267d6c91adda200d60</gtr:id><gtr:otherNames>Miyazaki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>doi_53d0760761407e72</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19BA5B1E-777C-4B81-A88D-5739ECC0F8D7</gtr:id><gtr:title>Assessment of colorectal hepatic metastases by quantitative T2 relaxation time.</gtr:title><gtr:parentPublicationTitle>European journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acddb263c240d3b24ba84f64a9eb1d63"><gtr:id>acddb263c240d3b24ba84f64a9eb1d63</gtr:id><gtr:otherNames>Raza SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0720-048X</gtr:issn><gtr:outcomeId>pm_15918_28_21724358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFBD8AE0-62C4-4DC6-969A-22A26A70D6F2</gtr:id><gtr:title>Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729cc526ae8a04a2a3c2b502c74fc08d"><gtr:id>729cc526ae8a04a2a3c2b502c74fc08d</gtr:id><gtr:otherNames>Simpkin CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>pm_15918_28_23426849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDC6CF8E-2AFF-478E-B5A3-861DAE711BE7</gtr:id><gtr:title>Dichloroacetate induces autophagy in colorectal cancer cells and tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34cf073710acda1f00a6fbaba4e34e9b"><gtr:id>34cf073710acda1f00a6fbaba4e34e9b</gtr:id><gtr:otherNames>Lin G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>545ca6f31b1820.49314284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E855B854-6A8A-413A-8B88-699AE0903867</gtr:id><gtr:title>Informatics in radiology: development of a research PACS for analysis of functional imaging data in clinical research and clinical trials.</gtr:title><gtr:parentPublicationTitle>Radiographics : a review publication of the Radiological Society of North America, Inc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ce8f6f187c75e51f6ffbc7dd1464d05"><gtr:id>3ce8f6f187c75e51f6ffbc7dd1464d05</gtr:id><gtr:otherNames>Doran SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-5333</gtr:issn><gtr:outcomeId>pm_15918_28_22929148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF91C7A9-CE1F-454F-9815-A29092E6B2B5</gtr:id><gtr:title>A framework for optimization of diffusion-weighted MRI protocols for large field-of-view abdominal-pelvic imaging in multicenter studies.</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e1a7d162daf951d7000ce7c1d14451"><gtr:id>68e1a7d162daf951d7000ce7c1d14451</gtr:id><gtr:otherNames>Winfield JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn><gtr:outcomeId>56d6d376d6ffd9.49296350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85E50D14-751B-4E85-B70F-C77FE9C02CBF</gtr:id><gtr:title>Body Diffusion-weighted MR Imaging in Oncology: Imaging at 3 T.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cb2b530ca6d8d3f3ecd9b026b702cd6"><gtr:id>7cb2b530ca6d8d3f3ecd9b026b702cd6</gtr:id><gtr:otherNames>Koh DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-9689</gtr:issn><gtr:outcomeId>56d6d0c5571a40.56415345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A8A7D3E-C080-48A8-97C2-EF4E4561241C</gtr:id><gtr:title>Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.</gtr:title><gtr:parentPublicationTitle>European journal of radiology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2352-0477</gtr:issn><gtr:outcomeId>58c68afa30f712.65123670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00D998F7-D309-4F6B-8B20-21ECE3D8F80F</gtr:id><gtr:title>Evaluation of diffusion models in breast cancer.</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71625485c3a90751092873829ed9f5c2"><gtr:id>71625485c3a90751092873829ed9f5c2</gtr:id><gtr:otherNames>Panek R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn><gtr:outcomeId>56d6d01b29a778.50084938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E430B4-6C1B-40C8-A6C9-013839AC4A44</gtr:id><gtr:title>Modelling DW-MRI data from primary and metastatic ovarian tumours.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e1a7d162daf951d7000ce7c1d14451"><gtr:id>68e1a7d162daf951d7000ce7c1d14451</gtr:id><gtr:otherNames>Winfield JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>56d6d01b66d3f2.47150440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3123F580-BBA2-4E31-9AA7-8C20A65E2A8A</gtr:id><gtr:title>Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fabccc804f86a9e49130364b2af4f070"><gtr:id>fabccc804f86a9e49130364b2af4f070</gtr:id><gtr:otherNames>Powell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>545ca830e295b2.17189178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87A2519D-EFFF-42C3-B044-0736E927ED59</gtr:id><gtr:title>Endovaginal magnetic resonance imaging of stage 1A/1B cervical cancer with A T2- and diffusion-weighted magnetic resonance technique: effect of lesion size and previous cone biopsy on tumor detectability.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ccd01b66a7a63eee0923b73dc37f0a0"><gtr:id>3ccd01b66a7a63eee0923b73dc37f0a0</gtr:id><gtr:otherNames>Charles-Edwards E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>RB35sV6A99i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B438313-CEF5-48FB-93F1-5ADF7D6BED78</gtr:id><gtr:title>Microstructure Characterization of Bone Metastases from Prostate Cancer with Diffusion MRI: Preliminary Findings.</gtr:title><gtr:parentPublicationTitle>Frontiers in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1c944ce5406cd62e7ed9dfa36e223fb"><gtr:id>b1c944ce5406cd62e7ed9dfa36e223fb</gtr:id><gtr:otherNames>Bailey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2234-943X</gtr:issn><gtr:outcomeId>5aa69fcb3c1f40.41653506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B3099EA-62EB-4EFA-B3BE-C35E9A3B6DCE</gtr:id><gtr:title>Towards a dosimetric framework for therapeutic ultrasound.</gtr:title><gtr:parentPublicationTitle>International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a0aeee24d087459c0e8fb640ea911a"><gtr:id>e8a0aeee24d087459c0e8fb640ea911a</gtr:id><gtr:otherNames>Shaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0265-6736</gtr:issn><gtr:outcomeId>56dd6ab77ac0c9.18789214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B014C7-1A2D-49D4-914B-3F98F98BF72E</gtr:id><gtr:title>Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95b7fb0f3ce4427089dd99fc73269a80"><gtr:id>95b7fb0f3ce4427089dd99fc73269a80</gtr:id><gtr:otherNames>Winfield J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ddaf7c553a14.59311692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A78003AD-7551-4908-BB57-73E1E27EF4CC</gtr:id><gtr:title>Imaging cervical cancer: recent advances and future directions.</gtr:title><gtr:parentPublicationTitle>Current opinion in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1040-8746</gtr:issn><gtr:outcomeId>pm_15918_28_21602677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7A5371C-CCB6-461D-921A-15982804C2F7</gtr:id><gtr:title>Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71625485c3a90751092873829ed9f5c2"><gtr:id>71625485c3a90751092873829ed9f5c2</gtr:id><gtr:otherNames>Panek R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d867257d30e5.40605175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD48250-E082-47D3-A62F-355E2AADEB37</gtr:id><gtr:title>Functional imaging in adult and paediatric brain tumours.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9e02657c63a09ff3c205dc9629081a"><gtr:id>3b9e02657c63a09ff3c205dc9629081a</gtr:id><gtr:otherNames>Peet AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>pm_15918_28_23149894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C792A4-3953-4FD5-96C3-7B662C10A8E9</gtr:id><gtr:title>Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545ca08f3b4cd9.70043882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62ACAA34-EAD6-4CE0-BEE8-0E8224BF3628</gtr:id><gtr:title>The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.</gtr:title><gtr:parentPublicationTitle>The oncologist</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/202e9131479c190e076e79a808a29cb3"><gtr:id>202e9131479c190e076e79a808a29cb3</gtr:id><gtr:otherNames>Castro E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1083-7159</gtr:issn><gtr:outcomeId>58c68af6c5c9d7.70068214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29564C3F-CB22-4080-BB17-513E0D31C6F0</gtr:id><gtr:title>Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>545ca08f60a016.98922634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3BAB5FD-6313-4873-B43A-C77D7D68CE84</gtr:id><gtr:title>Clinical proton MR spectroscopy in central nervous system disorders.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17043cd54786732c3f45bc12d7f04977"><gtr:id>17043cd54786732c3f45bc12d7f04977</gtr:id><gtr:otherNames>Oz G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>5464c5e059cc60.40547070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DF7927D-6A98-4688-B331-9AB770154C78</gtr:id><gtr:title>Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71625485c3a90751092873829ed9f5c2"><gtr:id>71625485c3a90751092873829ed9f5c2</gtr:id><gtr:otherNames>Panek R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn><gtr:outcomeId>58b820857a3b59.83469126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9060D95F-1766-49CF-BCB8-F48EB20C59FE</gtr:id><gtr:title>Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c223b2f0e0414de35acf200e7b37c29c"><gtr:id>c223b2f0e0414de35acf200e7b37c29c</gtr:id><gtr:otherNames>Harvey H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>58c68af51daeb8.82896863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C56FD14-C887-42A7-9BAD-072065EC0089</gtr:id><gtr:title>Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a46550536f71ae0700d347b8e82974b"><gtr:id>1a46550536f71ae0700d347b8e82974b</gtr:id><gtr:otherNames>Andreou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>pm_15918_28_23052642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C55304B3-DBFA-4128-8384-E150D065A05D</gtr:id><gtr:title>Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.</gtr:title><gtr:parentPublicationTitle>Academic radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1f9a321716837468dbae52014d31e9e"><gtr:id>d1f9a321716837468dbae52014d31e9e</gtr:id><gtr:otherNames>Arias-Mendoza F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1076-6332</gtr:issn><gtr:outcomeId>pm_15918_28_23931426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DBBBBEA-759B-461F-98F0-7973646F273C</gtr:id><gtr:title>Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f52fdf7de8e242ea40fb6b766cf424b4"><gtr:id>f52fdf7de8e242ea40fb6b766cf424b4</gtr:id><gtr:otherNames>Beloueche-Babari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_15918_28_23942066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43DC5D45-175B-4C11-8433-114F8B11CE37</gtr:id><gtr:title>Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomas.</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a97f10ddbaa1f65b5244339cc0b0736e"><gtr:id>a97f10ddbaa1f65b5244339cc0b0736e</gtr:id><gtr:otherNames>Carceller F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>5a786472a04a86.53200017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0958635C-81BD-4AD8-A861-7F5BC0A7A2AA</gtr:id><gtr:title>CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/144414971ab1933dcfdae8f750f0b95d"><gtr:id>144414971ab1933dcfdae8f750f0b95d</gtr:id><gtr:otherNames>Hunter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>5a361af4496e19.38820387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D3B3E8-B133-4F23-BE8D-3205E79891CB</gtr:id><gtr:title>Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_15918_28_23868012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C1803B0-EF3F-469C-A707-7A2DF677A40E</gtr:id><gtr:title>Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9897c98c1f78b93cc50c792bbb4b856"><gtr:id>c9897c98c1f78b93cc50c792bbb4b856</gtr:id><gtr:otherNames>Tunariu N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_15918_28_22281664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B203B5DB-0789-435B-94EB-BE2684791A92</gtr:id><gtr:title>Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Radiographics : a review publication of the Radiological Society of North America, Inc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0622c3b9042032fac7558aae59a4c315"><gtr:id>0622c3b9042032fac7558aae59a4c315</gtr:id><gtr:otherNames>Kyriazi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0271-5333</gtr:issn><gtr:outcomeId>TBUQNtN1dPJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F705F128-D399-48EF-A8D7-A5349FD3F9A6</gtr:id><gtr:title>Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19f3af8ec08be99a9d9d8e56cecdc344"><gtr:id>19f3af8ec08be99a9d9d8e56cecdc344</gtr:id><gtr:otherNames>Hill DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15918_28_24023724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C8E2155-8AF5-4590-8998-8A13C9265588</gtr:id><gtr:title>Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning.</gtr:title><gtr:parentPublicationTitle>Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4e5085f107cfdb223a786d813779295"><gtr:id>d4e5085f107cfdb223a786d813779295</gtr:id><gtr:otherNames>Guerreiro F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1120-1797</gtr:issn><gtr:outcomeId>58c68af5da0d55.19952076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5685253F-6722-43AE-9409-DF3CCECE7B32</gtr:id><gtr:title>The use of high-intensity focused ultrasound as a novel treatment for painful conditions-a description and narrative review of the literature.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3869996b0da26da8cad63cc554af1f1"><gtr:id>e3869996b0da26da8cad63cc554af1f1</gtr:id><gtr:otherNames>Brown MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn><gtr:outcomeId>56d8b331ebf283.04244429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EC612D0-C525-4039-A094-84F177F98103</gtr:id><gtr:title>DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.</gtr:title><gtr:parentPublicationTitle>Topics in magnetic resonance imaging : TMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e1a7d162daf951d7000ce7c1d14451"><gtr:id>68e1a7d162daf951d7000ce7c1d14451</gtr:id><gtr:otherNames>Winfield JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0899-3459</gtr:issn><gtr:outcomeId>58c68af7b5a512.33841990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9DFD31E-D8B0-430B-9803-34A42FBAADAA</gtr:id><gtr:title>International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions.</gtr:title><gtr:parentPublicationTitle>International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e15c333c2e3b2707b428a11cff6397c"><gtr:id>9e15c333c2e3b2707b428a11cff6397c</gtr:id><gtr:otherNames>Huisman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0265-6736</gtr:issn><gtr:outcomeId>56dd6ab7568731.07877330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2CACD05-2A3D-4D1B-8DC6-130C994C9F85</gtr:id><gtr:title>Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e1a7d162daf951d7000ce7c1d14451"><gtr:id>68e1a7d162daf951d7000ce7c1d14451</gtr:id><gtr:otherNames>Winfield JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>58c68af654ffc5.42611259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A61DE48-8F2E-47CB-9BCF-9C82761D595C</gtr:id><gtr:title>Rationale for Modernising Imaging in Advanced Prostate Cancer.</gtr:title><gtr:parentPublicationTitle>European urology focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e47775021cf8b9e0c33c83d67678519"><gtr:id>1e47775021cf8b9e0c33c83d67678519</gtr:id><gtr:otherNames>Padhani AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2405-4569</gtr:issn><gtr:outcomeId>5aa6b04d7eb682.53428598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6C93387-920A-4042-ACF6-0D3A4D62CDC9</gtr:id><gtr:title>Initial experience of the BREAST-Q breast-conserving therapy module.</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b4adf0e12bc8481fbe79ee12caeed13"><gtr:id>2b4adf0e12bc8481fbe79ee12caeed13</gtr:id><gtr:otherNames>O'Connell RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>58c68af741be20.13607437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD68787-519A-4632-B0BE-E261F51BC867</gtr:id><gtr:title>Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f31ee6c5ba0018c13f35f6e50aac1fd"><gtr:id>4f31ee6c5ba0018c13f35f6e50aac1fd</gtr:id><gtr:otherNames>Weller A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>58c68af89e1e23.05428998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB26DE1A-80E7-40BC-8672-8215252ACF21</gtr:id><gtr:title>Diffusion-weighted imaging of the high-risk breast: Apparent diffusion coefficient values and their relationship to breast density.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>545ca7a05adca7.99571859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9CFD4DD-AD45-404A-A132-08303530EFDE</gtr:id><gtr:title>Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>pm_15918_28_22367471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>078A739E-29E2-4786-89DA-3941EF93C934</gtr:id><gtr:title>Breast dynamic contrast-enhanced examinations with fat suppression: are contrast-agent uptake curves affected by magnetic field inhomogeneity?</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2328d2c3a7eb27451f1a96bd20528084"><gtr:id>2328d2c3a7eb27451f1a96bd20528084</gtr:id><gtr:otherNames>Schmidt MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>doi_53cfd4fd4a64ec0b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25C9EB90-181B-44C8-8E69-ADE10153845D</gtr:id><gtr:title>Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0622c3b9042032fac7558aae59a4c315"><gtr:id>0622c3b9042032fac7558aae59a4c315</gtr:id><gtr:otherNames>Kyriazi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>peMmkZSFBRs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F29B5FE-F47B-4A18-BBA0-D57B60CA1414</gtr:id><gtr:title>Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular Tissue.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3228f5aaf12b77832859056a54758903"><gtr:id>3228f5aaf12b77832859056a54758903</gtr:id><gtr:otherNames>Ledger AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b82086dc37b5.82716296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056246A7-851F-4348-90F2-2CD582983D0A</gtr:id><gtr:title>Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d6d3763df009.10154148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>267E6AE7-5FBD-4C07-A122-94EFEB356B75</gtr:id><gtr:title>Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/782255054529689a5c2a609e566a9f12"><gtr:id>782255054529689a5c2a609e566a9f12</gtr:id><gtr:otherNames>Graham TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn><gtr:outcomeId>545ca08e8c9af5.71639329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B58791D5-6600-48F7-B9AA-5C452C18C229</gtr:id><gtr:title>Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1028eaed17bea4a521d32b3ed39f897e"><gtr:id>1028eaed17bea4a521d32b3ed39f897e</gtr:id><gtr:otherNames>Riches SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>545ca83187cbf1.53705335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA921E6-8DE2-4215-939C-18CC3B0E58F3</gtr:id><gtr:title>Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14feb638d62f8a29dda2d0fb9c404217"><gtr:id>14feb638d62f8a29dda2d0fb9c404217</gtr:id><gtr:otherNames>Payne GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>58b82085a328e2.35140824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A63F49F9-43A8-49CA-8732-87FA65738C98</gtr:id><gtr:title>Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>545266fd850734.92772099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A52FB26-2ACA-46E8-AF65-39165B3D08AF</gtr:id><gtr:title>Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6d8c0079e1a527682983beed0941bd6"><gtr:id>e6d8c0079e1a527682983beed0941bd6</gtr:id><gtr:otherNames>Giles SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>CLffEMDN7vo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A7785A5-7CB9-44B2-9424-9518AE069978</gtr:id><gtr:title>Computed diffusion-weighted MR imaging may improve tumor detection.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ba091a36aebcaf23ad9fff21ea3847"><gtr:id>02ba091a36aebcaf23ad9fff21ea3847</gtr:id><gtr:otherNames>Blackledge MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>BDit25J5CN2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>104E5730-8A94-40CF-B962-C2602931444D</gtr:id><gtr:title>Combination of chemical suppression techniques for dual suppression of fat and silicone at diffusion-weighted MR imaging in women with breast implants.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cb2b530ca6d8d3f3ecd9b026b702cd6"><gtr:id>7cb2b530ca6d8d3f3ecd9b026b702cd6</gtr:id><gtr:otherNames>Koh DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>pm_15918_28_22706913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20D944A5-8E36-40A5-ADD2-2C6443449A9E</gtr:id><gtr:title>Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f52fdf7de8e242ea40fb6b766cf424b4"><gtr:id>f52fdf7de8e242ea40fb6b766cf424b4</gtr:id><gtr:otherNames>Beloueche-Babari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>iiJ4ZnZddF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33540C1D-37A9-4C57-9065-0763743C295B</gtr:id><gtr:title>Alternative screening for dense breasts: MRI.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>56d8b332cb59f5.81253914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D191313-DE83-488F-AC09-DDC1F3CB0708</gtr:id><gtr:title>Quality assurance in MRI breast screening: comparing signal-to-noise ratio in dynamic contrast-enhanced imaging protocols.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131c41688be7a01aca68ec749ba99a5f"><gtr:id>131c41688be7a01aca68ec749ba99a5f</gtr:id><gtr:otherNames>Kousi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>56d86725a79e69.44948771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39A2ABFE-7C54-49C6-AC99-22B9A9A3DEE0</gtr:id><gtr:title>Computerized detection of breast lesions in multi-centre and multi-instrument DCE-MR data using 3D principal component maps and template matching.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286174951d92c80a11eb1f2ddc421799"><gtr:id>286174951d92c80a11eb1f2ddc421799</gtr:id><gtr:otherNames>Ertas G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>doi_53d0400406a1bbb7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACAE6754-BE50-4744-8988-EDF8034E2DCC</gtr:id><gtr:title>Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc621d58f5b5c7aef71cdfc63925c6c"><gtr:id>1dc621d58f5b5c7aef71cdfc63925c6c</gtr:id><gtr:otherNames>Harding D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>5a8c3fb6c9f621.41405821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D1552D2-0121-4A69-8B83-9C422071C632</gtr:id><gtr:title>Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f61520d03ee3c8ed8d42d917137ecd16"><gtr:id>f61520d03ee3c8ed8d42d917137ecd16</gtr:id><gtr:otherNames>Taouli B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d6d3760b1366.28282145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F00551A-C756-4098-8DBC-8FE28D20EB98</gtr:id><gtr:title>New MR techniques in gynecologic cancer.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04d81a31fc7f6fa96e2de95c7264dad1"><gtr:id>04d81a31fc7f6fa96e2de95c7264dad1</gtr:id><gtr:otherNames>Wakefield JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>pm_15918_28_23345344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED28B69D-B5F8-47A5-A2B7-C7AFA216BC43</gtr:id><gtr:title>A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck.</gtr:title><gtr:parentPublicationTitle>Magma (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7023e614b47c3b3ad4d0858e51a933a"><gtr:id>d7023e614b47c3b3ad4d0858e51a933a</gtr:id><gtr:otherNames>Whitcher B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-5243</gtr:issn><gtr:outcomeId>pm_15918_28_21203797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF0DAF89-3C81-45BA-8519-1CD118D04A46</gtr:id><gtr:title>Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cad386d6426596bcb4d1e268b2077ec"><gtr:id>1cad386d6426596bcb4d1e268b2077ec</gtr:id><gtr:otherNames>Morgan VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>pm_15918_28_22357998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A5F4D7D-6765-4159-8DEF-E414D717A12F</gtr:id><gtr:title>The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT).</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b4adf0e12bc8481fbe79ee12caeed13"><gtr:id>2b4adf0e12bc8481fbe79ee12caeed13</gtr:id><gtr:otherNames>O'Connell RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>5a8c3fb650ae40.81557937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F748DF3E-4111-4A38-9E24-2A11DA224527</gtr:id><gtr:title>Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cad386d6426596bcb4d1e268b2077ec"><gtr:id>1cad386d6426596bcb4d1e268b2077ec</gtr:id><gtr:otherNames>Morgan VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>oziXLRgdbrA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE4979D-3C2F-4657-B6A3-161D9203DB0B</gtr:id><gtr:title>Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71625485c3a90751092873829ed9f5c2"><gtr:id>71625485c3a90751092873829ed9f5c2</gtr:id><gtr:otherNames>Panek R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>5936ac0ca80d82.53003390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48C57172-1491-4A32-8B12-18D769CCA065</gtr:id><gtr:title>An evaluation of motion compensation strategies and repeatability for abdominal (1)H MR spectroscopy measurements in volunteer studies and clinical trials.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a04c049f791a9e5427b91ff4e1b0dcf"><gtr:id>3a04c049f791a9e5427b91ff4e1b0dcf</gtr:id><gtr:otherNames>Germuska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_15918_28_22190219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45F1E111-DB63-4046-BD0D-E78A76098F47</gtr:id><gtr:title>Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc621d58f5b5c7aef71cdfc63925c6c"><gtr:id>1dc621d58f5b5c7aef71cdfc63925c6c</gtr:id><gtr:otherNames>Harding D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>5aa6b4601ec212.61438858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D054EAA-7147-4F8C-B1F4-A7FF9936FC05</gtr:id><gtr:title>Imaging biomarker roadmap for cancer studies.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5261e64d77ae945d18be26d2f9a33824"><gtr:id>5261e64d77ae945d18be26d2f9a33824</gtr:id><gtr:otherNames>O'Connor JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>58b820835c6d18.38057663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2573E25-4FD2-4B92-95A8-55D236BB4455</gtr:id><gtr:title>Distortion correction of echo-planar diffusion-weighted images of uterine cervix.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d6d3774964a0.99656547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBC859DD-257F-4F3B-AA8D-099515AB684A</gtr:id><gtr:title>Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14feb638d62f8a29dda2d0fb9c404217"><gtr:id>14feb638d62f8a29dda2d0fb9c404217</gtr:id><gtr:otherNames>Payne GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>P8pEdVoyDHL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9261B40B-5A02-4387-851D-02D189A6D0FC</gtr:id><gtr:title>In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1f9a321716837468dbae52014d31e9e"><gtr:id>d1f9a321716837468dbae52014d31e9e</gtr:id><gtr:otherNames>Arias-Mendoza F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>cE1WHuppCja</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB215BAA-BB2A-4E05-9CCF-D27F069390B0</gtr:id><gtr:title>Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7467eb7cc41ac20f5e252118c328720"><gtr:id>b7467eb7cc41ac20f5e252118c328720</gtr:id><gtr:otherNames>Just N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_15918_28_21290457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8BBC53E-D653-409D-8FAE-AA29C7EC2649</gtr:id><gtr:title>Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>56d8b3324c40b0.34117540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>683B8F80-6479-4D95-83D8-6940507AB642</gtr:id><gtr:title>Functional magnetic resonance: biomarkers of response in breast cancer.</gtr:title><gtr:parentPublicationTitle>Breast cancer research : BCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-5411</gtr:issn><gtr:outcomeId>ifE11QASR3o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F868489-776E-43BB-82B0-5DC6C78193F2</gtr:id><gtr:title>Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1558589cce0de0c805eb83e2891241"><gtr:id>fe1558589cce0de0c805eb83e2891241</gtr:id><gtr:otherNames>Borri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675f57f29a06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03F59C25-45D6-427B-ACF1-FAD54CC46803</gtr:id><gtr:title>Imaging: standardizing the use of functional MRI in prostate cancer.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-4812</gtr:issn><gtr:outcomeId>pm_15918_28_21321573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FED5E33-80E4-4842-AAE0-87D28A7961FE</gtr:id><gtr:title>Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dce19ccc7ddf0e94e8dbad648eda3bb2"><gtr:id>dce19ccc7ddf0e94e8dbad648eda3bb2</gtr:id><gtr:otherNames>Messiou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>F93oiRRA9He</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B018E368-671A-4891-AD9C-23673C42F8E1</gtr:id><gtr:title>Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14feb638d62f8a29dda2d0fb9c404217"><gtr:id>14feb638d62f8a29dda2d0fb9c404217</gtr:id><gtr:otherNames>Payne GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>56d86726089302.01270206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0121856-04FC-4F1A-8AFC-FC39256B23CA</gtr:id><gtr:title>Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>545266fdaf5491.10408095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2CD7A9F-F491-4382-B794-7807E3116B8F</gtr:id><gtr:title>Functional MR Imaging in Gynecologic Cancer.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-9689</gtr:issn><gtr:outcomeId>56d8b331ca7f39.99798477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C922195-E3D0-4313-8F4C-30064612FDB1</gtr:id><gtr:title>Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c021039d9ce8c883962ed24f5c55add"><gtr:id>6c021039d9ce8c883962ed24f5c55add</gtr:id><gtr:otherNames>Wong KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>5a9d2af83d3cd6.14195995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F5AC52-D413-4A94-80EA-57DB15974588</gtr:id><gtr:title>Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dce19ccc7ddf0e94e8dbad648eda3bb2"><gtr:id>dce19ccc7ddf0e94e8dbad648eda3bb2</gtr:id><gtr:otherNames>Messiou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>doi_53d07607614a5123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45188866-1C21-4C5D-B764-61E2CD09C7CD</gtr:id><gtr:title>Determining the chemical exchange saturation transfer (CEST) behavior of citrate and spermine under in vivo conditions.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c888bf5ce01437df710f750fd71145d0"><gtr:id>c888bf5ce01437df710f750fd71145d0</gtr:id><gtr:otherNames>Basharat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>58c68af8335c14.09327292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81C922DF-C4CB-4B56-BCF4-791A032CCF72</gtr:id><gtr:title>Radiotherapy planning using MRI.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2328d2c3a7eb27451f1a96bd20528084"><gtr:id>2328d2c3a7eb27451f1a96bd20528084</gtr:id><gtr:otherNames>Schmidt MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>56d6d01c20d445.79089035</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701533</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>